Loncar Cancer Immunotherapy ETF (CNCR) ETF

Expense Ratio: 0.79% | AUM: 32.82M | Issuer: Exchange Traded Concepts

CNCR Daily Price Range
CNCR 52-Week Price Range

CNCR - Real-Time SMART Grade™

C
Neutral

Overall SMART Grade

CNCR has a real-time SMART Grade of C (Neutral).

Learn More About SMART Grades™

CNCR - Profile & Info


The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.

Issuer Exchange Traded Concepts
Expense Ratio 0.79%
Assets Under Management (AUM) 32.82M
Underlying Index Loncar Cancer Immunotherapy Index
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $22.64
Options? No
Total Holdings N/A

CNCR - News


View All CNCR News

CNCR - Price/Volume Stats

Current price $22.10
Prev. close $22.61
Day low $22.07
Day high $22.50
52-week high $26.47
52-week low $19.82
Day Volume 8,500
Avg. volume 16,345
Dividend yield 0.47%

CNCR - Recent Returns

1-mo -6.67%
3-mo -0.72%
6-mo -5.31%
1-year -4.25%
3-year N/A
5-year N/A
YTD 4.05%
2016 -25.63%
2015 N/A
2014 N/A
2013 N/A
2012 N/A

CNCR - Stock Chart


CNCR - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
Page generated in 2.2115 seconds.